Mirum registers Phase 2 trial of maralixibat for cholestasis of pregnancySep 16Trial updatemaralixibatMirum Pharmaceuticals, Inc.
Mirum raises 2026 sales guidance, volixibat gets FDA breakthrough status for PSCAug 5Quarterly updateMirum Pharmaceuticals, Inc.volixibat
Mirum registers Phase 1 ADME trial for MRM-3379 in healthy male volunteersJul 17Trial updateMirum Pharmaceuticals, Inc.MRM-3379
Sign in